Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases.
about
A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdoseImpact of Age and Sex on QT Prolongation in Patients Receiving PsychotropicsCardiovascular considerations in antidepressant therapy: an evidence-based reviewAn agenda for research on adverse drug reactionsPredictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trialIntravenous lipid administration for drug-induced toxicity: a critical review of the existing data.Ventricular dysrhythmias associated with poisoning and drug overdose: a 10-year review of statewide poison control center data from California.Norepinephrine transporter function and human cardiovascular disease.Evaluation of a QT nomogram for risk assessment after antidepressant overdose.Antidepressant prescribing patterns in Korea: results from the clinical research center for depression studyA consensus statement for safety monitoring guidelines of treatments for major depressive disorder.Benzothiazoles as probes for the 5HT1A receptor and the serotonin transporter (SERT): a search for new dual-acting agents as potential antidepressants.Clinical use of antidepressant therapy and associated cardiovascular riskEffects of antidepressants, but not psychopathology, on cardiac sympathetic control: a longitudinal study.Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.A comparison of venlafaxine and SSRIs in deliberate self-poisoningDrug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice.Variability in the quality of overdose advice in Summary of Product Characteristics (SPC) documents: gut decontamination recommendations for CNS drugsSelective Serotonin-norepinephrine Reuptake Inhibitors-induced Takotsubo CardiomyopathyElectrocardiogram changes and arrhythmias in venlafaxine overdose.Venlafaxine-Induced Cytotoxicity Towards Isolated Rat Hepatocytes Involves Oxidative Stress and Mitochondrial/Lysosomal Dysfunction.QT prolongation in the intensive care unit: commonly used medications and the impact of drug-drug interactions.Cushing's Syndrome and Treatment-Resistant Depression.QTc interval prolongation by d-propoxyphene: what about other analgesics?Cardiovascular adverse effects of newer antidepressants.Risk of QT/QTc prolongation among newer non-SSRI antidepressants.An 11-year retrospective review of venlafaxine ingestion in children from the California Poison Control System.Intravenous Lipid Emulsion as an Antidote for the Treatment of Acute Poisoning: A Bibliometric Analysis of Human and Animal Studies.Desvenlafaxine overdose and the occurrence of serotonin toxicity, seizures and cardiovascular effects.Suicidal Intent and Method of Self-Harm: A Large-scale Study of Self-Harm Patients Presenting to a General Hospital.Single-agent duloxetine ingestions.Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double-blind, placebo-controlled study of orthostatic challenge, blood pressure and heart rate.Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials.Patterns of antiepileptic drug overdose differ between men and women: admissions to the Edinburgh Poisons Unit, 2000-2007.Altered platelet contents in survivors of early ischemic ventricular fibrillation: preliminary findings.Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.Duloxetine-associated tachycardia.The spectrum of acute heart failure after venlafaxine overdose.The incidence and associated risk factors for sudden unexplained death in psychiatric in-patients in England and Wales.Pharmacokinetic/pharmacodynamic modeling of cardiac toxicity in human acute overdoses: utility and limitations
P2860
Q24606269-5C7C072A-A0B4-4C46-AC92-9985D0EB01B8Q26801837-BFB0ADA1-887B-4E96-9B85-834C9939D207Q27021843-E0DEB6C9-9555-46B4-8E25-74C43B109A10Q28469318-F0706B07-9C74-4E5E-804C-270B33A976F2Q28710054-6B5BFA9A-EF8C-40AD-A8F8-86C6154C3F4BQ30560879-2815A46D-FF65-4903-A068-BD8FE63C5BEEQ30883223-BB7DD3FB-7118-4B1E-9188-030B0493EBA4Q33161828-BA782863-8EF4-4222-A743-304C6257AF46Q34457439-B62ACDD7-0EC7-4578-AADD-2D01A3ECC52EQ35238344-DADCEE29-0C40-48C8-8ED0-724929838D55Q35311467-504783C4-C72F-43B1-8347-035E57EBC3D1Q35992330-DCF34269-AD73-4869-9EA7-B90140E4F953Q36184863-3924ED37-0C08-433E-BD0A-E30B16FCF339Q36234258-EDF255D2-FDCF-40B8-9B28-4EC36DE115F8Q36514240-03641968-6D04-4566-AAB9-35AEE2A780AFQ36549123-48D14684-D449-453A-9BA2-8891104ACCBAQ36987981-1901AF6E-46FA-409C-8D31-76E8BD5EE884Q37156285-1489F4FE-88D2-46E3-BF6C-AE070C35F981Q37170251-DA922A65-0613-4861-9896-E513E645776AQ37201707-EBE220C4-EB91-4AE6-A592-5256EACEB051Q37590725-38B6450D-4E87-4801-A790-09209EE5831DQ37727223-DFB7608D-A0E5-4E6E-9AA8-5F712F3538A5Q37743723-53EA14A5-9FCE-4928-B3D8-B0633EBBB7D7Q38008460-BB4C5F33-9847-4F06-BE00-0044655F0B38Q38205025-C23E5E92-27AA-41A4-AA02-D342CEDC5E9AQ38247487-AED994DC-3AAB-4755-B2C1-21CCF7607AF7Q38583272-FC0301C0-D241-4AEE-9DDA-FFCDC45F071CQ39836341-7844C1E2-94A7-49BC-921E-7A6F06E2D3CBQ40583867-8C3767EC-96FA-42CB-A9F2-D84F8E543081Q41009334-2CBC271E-8255-4FF4-A81A-C78A0CB75F82Q43446891-BBA25ADB-7F48-4FE5-B24D-E5613A2BAC47Q43848135-E7911B5D-AA05-40DF-9701-D43CBB891AE6Q44463295-A743DB4D-5B5C-40F1-BE79-14113DB6C351Q44747493-F3C0B728-B2B5-4FB3-9E67-40698CF1203DQ45164756-BAD83416-03A6-47F3-9752-DB76E72836ADQ45183391-6568A214-C7C9-4A4F-AC05-6E4BB85E67E1Q46410698-0B52F98C-25DF-4F3C-9A2A-498F89BA24BFQ48543757-07AE6FEB-011C-4BF1-A894-2B8ABDC33966Q51833332-E21061DA-7245-4E5E-8ECB-8C1F24A6FBFEQ57016826-11A9D8CC-E1BC-4084-90FB-891BFBD3AD87
P2860
Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Cardiovascular toxicity due to ...... view of 235 consecutive cases.
@ast
Cardiovascular toxicity due to ...... view of 235 consecutive cases.
@en
type
label
Cardiovascular toxicity due to ...... view of 235 consecutive cases.
@ast
Cardiovascular toxicity due to ...... view of 235 consecutive cases.
@en
prefLabel
Cardiovascular toxicity due to ...... view of 235 consecutive cases.
@ast
Cardiovascular toxicity due to ...... view of 235 consecutive cases.
@en
P2860
P1476
Cardiovascular toxicity due to ...... view of 235 consecutive cases.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.2007.02849.X
P407
P577
2007-02-12T00:00:00Z